The Face & Body Place By Dr. Kimberly Finder, M.D.

Dr. Kimberly Finder Education & Training



Dr. Kimberly Finder CV


  • University of Texas Medical School at Houston, MD in 1984
  • Internship Hospital
    Madigan Army Medical Center, completed in 1985
  • Residency
    Brooke Army Medical Center, completed in 1990


  • The University Of Texas at Austin, BS in 1978


  • Healthgrades Honor Roll*

*Healthgrades Recognized Doctor designation identifies leading doctors who are:

  • Board-certified dermatologist
  • Have not had their license surrendered or revokes since Healthgrades started collecting data in 2000
  • Have no malpractice judgments, adverse arbitration awards, or monetary settlements for the last five years in the states in which Healthgrades can collect malpractice data.
  • Are free of state or federal disciplinary actions (sanctions) for the last five years


“Hypergammaglobulinemic purpura of Waldenström”

Kimberly A. Finder, CPT(P), MC, USA1
Martha L. McCollough, MAJ, MC, USA1 ,
Steven L. Dixon, MD1 ,
Andrew J. Majka, MD1
William Jaremko, MAJ, MC, USAF1
From the Dermatology Service, Department of Medicine, Brooke Army Medical Center.

Journal of the American Academy of Dermatology, October 1990, Volume 23, Issue 4, Part 1, Pages 669–676

Hypergammaglobulinemic purpura of Waldenström is characterized by hypergammaglobulinemia, recurring purpura, an elevated erythrocyte sedimentation rate, and the presence of rheumatoid factor indicative of circulating immune complexes. There is a significant association with autoimmune diseases, especially Sjögren’s syndrome and lupus erythematosus, Hypergammaglobulinemic purpura is considered primary when there is no other associated disease or secondary when associated with other diseases, usually autoimmune. Immune derangements are fundamental in its pathogenesis, although its cause is still unknown. Therapy is unrewarding and is probably unnecessary for this usually benign condition. Three cases are presented that are representative of patients with hypergammaglobulinemic purpura.